David A. Barton

Melbourne, VIC, AU 
Melbourne, VIC, AU 

Overview

David Barton practices practicing medicine in Melbourne, Australia.

His clinical expertise encompasses Vascular Dementia, Alzheimer's Disease, Dementia, and CACH Syndrome.

He is actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Melbourne, VIC, Australia
Other Locations
Carlton, TAS, Australia
Carlton, VIC, Australia
Noble Park, VIC, Australia
North Melbourne, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: June 12, 2026
Intervention Type: Drug
Study Drug: LY3372689
Study Phase: Phase 2
Deferiprone to Delay Dementia (The 3D Study): a Clinical Proof of Concept Study
Deferiprone to Delay Dementia (The 3D Study): a Clinical Proof of Concept Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Deferiprone
Study Phase: Phase 2
Interactions Between The Serotonin Transporter And Sympathetic Nervous System Activation In Patients With Major Depressive Disorder - Understanding The Link Between The Brain And The Heart
Interactions Between The Serotonin Transporter And Sympathetic Nervous System Activation In Patients With Major Depressive Disorder - Understanding The Link Between The Brain And The Heart
Enrollment Status: Completed
Publish Date: September 14, 2023
Intervention Type: Drug
Study Drug: Selective Serotonin Re-Uptake Inhibitor (SSRI) Antidepressant
Study Phase: Phase 4
A Randomised Trial Examining the Effectiveness of Sympathetic Nervous Inhibition in Alleviating the Metabolic Side Effects of Antipsychotic Medications in Patients With Schizophrenia
A Randomised Trial Examining the Effectiveness of Sympathetic Nervous Inhibition in Alleviating the Metabolic Side Effects of Antipsychotic Medications in Patients With Schizophrenia
Enrollment Status: Withdrawn
Publish Date: April 24, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials

26 Total Publications

Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.
Journal: The British journal of psychiatry : the journal of mental science
Published: July 06, 2026

Frequently Asked Questions about David A. Barton

Is David A. Barton a top-rated expert for Vascular Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. David A. Barton is classified as an Experienced expert for Vascular Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does David A. Barton participate in research or clinical trials?

Yes. David A. Barton has published 26 articles and abstracts on conditions like Vascular Dementia. You can view a list of David A. Barton's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Barton's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile